Champions Oncology (CSBR) Shares Outstanding (Weighted Average) (2011 - 2026)

Champions Oncology's Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $13.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 1.36% year-over-year to $13.9 million; the TTM figure through Jan 2026 stood at $13.9 million (up 1.36% YoY), while the FY2025 annual figure was $13.7 million, up 0.83% from the prior year.
• Shares Outstanding (Weighted Average) was $13.9 million for Q1 2026 at Champions Oncology, up from $13.8 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $13.9 million in Q1 2026 to a low of $13.2 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $13.6 million across 5 years, with a median of $13.6 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) declined 1.5% in 2022, then rose 2.94% in 2023.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $13.5 million in 2022, then dropped by 0.23% to $13.5 million in 2023, then gained by 0.72% to $13.6 million in 2024, then grew by 1.46% to $13.8 million in 2025, then advanced by 0.69% to $13.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $13.9 million (Q1 2026), $13.8 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.